IONS
Ionis PharmaceuticalsยทNASDAQ
--
--(--)
--
--(--)
IONS Profile
Ionis Pharmaceuticals, Inc.
The leader in RNA-targeted therapy and pioneering new markets and changing standards of care with its novel antisense technology
2855 Gazelle Court, Carlsbad, CA 92010
--
Ionis Pharmaceuticals, Inc. was incorporated in California in 1989 and changed its state of incorporation to Delaware in January 1991. The company has spent three decades developing RNA-targeted drugs and has grown into a fully integrated commercial-stage biotechnology company with seven listed drugs and a strong pipeline across neurology, cardiometabolic diseases and other high-demand areas for patients. It continues to advance next-generation RNA targeting technologies through independent and collaborative development to deliver innovative therapies to patients with serious diseases.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
